DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Public ClinicalTrials.gov record NCT06953089. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multicenter, Open-Label Trial of DB-1311 in Combination With BNT327 or DB-1305 in Participants With Advanced/Metastatic Solid Tumors
Study identification
- NCT ID
- NCT06953089
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- DualityBio Inc.
- Industry
- Enrollment
- 492 participants
Conditions and interventions
Conditions
Interventions
- BNT327 Drug
- DB-1305/BNT325 Drug
- DB-1311/BNT324 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 17, 2025
- Primary completion
- Jun 29, 2030
- Completion
- Jun 29, 2030
- Last update posted
- Feb 5, 2026
2025 – 2030
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| USA06-0 | Los Angeles | California | 90025 | Recruiting |
| USA16-0 | Los Angeles | California | 90025 | Recruiting |
| USA01-0 | Wheat Ridge | Colorado | 80033 | Recruiting |
| USA08-0 | Florida City | Florida | 99208 | Recruiting |
| USA10-0 | Atlanta | Georgia | 30318 | Recruiting |
| USA11-0 | Bethesda | Maryland | 20817 | Recruiting |
| USA14-0 | Lincoln | Nebraska | 68506 | Recruiting |
| USA04-0 | New York | New York | 10032 | Recruiting |
| USA15-0 | Portland | Oregon | 97239 | Recruiting |
| USA03-0 | Charleston | South Carolina | 29425 | Recruiting |
| USA13-0 | Anderson | Texas | 46011 | Recruiting |
| USA12-0 | Houston | Texas | 77030 | Recruiting |
| USA05-0 | Virginia Beach | Virginia | 22031 | Recruiting |
| USA09-0 | Puyallup | Washington | 98373 | Recruiting |
| USA07-0 | Spokane | Washington | 99208 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06953089, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 5, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06953089 live on ClinicalTrials.gov.